Investor Relations

Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII) provides biological based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. As a leader in alternatives to conventional pesticides, MBII has a proven go-to-market strategy and remains on the cutting edge of developing the types of biological products in which today’s farmers are increasingly interested.

Learn more

Wednesday, November 10, 2021

Marrone Bio Innovations will present Q3 Earnings Results via Conference Call and Webcast at 4:30 p.m. Eastern Time

August 2020

Newly appointed CEO, Kevin Helash, shares his background, what brought him to Marrone Bio Innovations and insights on the company's Q2 earnings results.

Press Releases

view all